197 - The Alphabet of New Anti-Mycobacterial Medications

Saturday, October 22, 2022

8:00 AM – 9:00 AM US ET

Location: 204 ABC

Watch the live stream on the conference website.

All relevant financial disclosures have been mitigated.

Moderator(s)

Sapna Morris, MD

Medical Officer
Centers for Disease Control and Prevention
Atlanta, GA, United States

Disclosure(s): No financial relationships to disclose
Pennan Barry, MD, MPH

Chief, Surveillance and Epidemiology Section, Tuberculosis Control Branch
California Department of Public Health
RICHMOND, CA, United States

Disclosure(s): No financial relationships to disclose

Slides

Faculty(s)

Elisa Ignatius, MD, MSc

Assistant Professor
Johns Hopkins

Disclosure(s): No financial relationships to disclose

Slides
Kevin Winthrop, MD, MPH

Professor, Infectious Diseases, Ophthalmology Professor, Public Health and Preventive Medicine
OHSU-PSU School of Public Health
Portland, Oregon, United States

Disclosure(s): No financial relationships to disclose

Slides
Pennan Barry, MD, MPH

Chief, Surveillance and Epidemiology Section, Tuberculosis Control Branch
California Department of Public Health
RICHMOND, CA, United States

Disclosure(s): No financial relationships to disclose

Slides

Disclosure(s):

Sapna B. Morris, MD: No financial relationships to disclose

Pennan Barry, MD, MPH: No financial relationships to disclose

Elisa H. Ignatius, MD, MSc: No financial relationships to disclose

Kevin L. Winthrop, MD, MPH: No financial relationships to disclose

CME Credits: Maximum of 1 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1 hours of MOC Credit
CNE Credits: Maximum of 1 hours of ANCC Credit
ACPE Credits: ACPE 1 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-0000-22-002-L01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

integrate pharmacokinetic information into designing treatment regimens for the treatment of TB and NTM disease;
describe current and evolving guidance for treatment of MDR tuberculosis;
identify current therapeutic approaches to NTM and new compounds in development;
describe the importance of clinical pharmacology in mycobacterial drug development and regimen selection

Presentations:

8:00 AM – 8:20 AM US ET

Understanding the Pharmacokinetics of Newer Meds to Treat TB and NTM
Speaker: Elisa H. Ignatius, MD, MSc – Johns Hopkins
8:20 AM – 8:40 AM US ET

Hard-to-Treat NTMs; Putting New Regimens to Work
Speaker: Kevin L. Winthrop, MD, MPH – OHSU-PSU School of Public Health
8:40 AM – 9:00 AM US ET

MDR TB Treatment With All Oral, Shorter Regimens, Is It All Good News?
Speaker: Pennan Barry, MD, MPH – California Department of Public Health